ATCC and the Broad Institute of MIT and Harvard today announced new research describing the development of engineered ...

Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part because researchers lack reliable ways to recreate the conditions cancer ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity ...

As a student in William & Mary’s biology master’s program, Keegan Sweeney ‘26 is fascinated with the translational aspect of research — how studying organisms such as yeast can improve our ...

Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether hyperactivating growth genes, rather than inhibiting them, improves outcomes.